High Throughput Screening Market Growth Drivers and Forecast by 2028: https://www.theinsightpartners.....com/reports/high-th
The high throughput screening market is projected to reach US$ 28,255.71 million by 2028 from US$ 15,997.47 million in 2021. The market is estimated to grow with a CAGR of 8.5% from 2021 to 2028. High-throughput screening (HTS) is a drug discovery method that enables automated testing of various chemical or biological compounds for a specific biological target. High-throughput screening methods are widely used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a significant number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can soon be screened cost-effectively. HTS is a valuable tool for assessing pharmacological targets, pharmacologically profiling agonists, and antagonists for receptors (such as GPCRs) and enzymes.
